Summit Global Investments Purchases Shares of 4,298 National HealthCare Corporation $NHC

Summit Global Investments purchased a new stake in shares of National HealthCare Corporation (NYSEAMERICAN:NHC) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 4,298 shares of the company’s stock, valued at approximately $908,000.

Other institutional investors have also recently made changes to their positions in the company. Morgan Stanley Institutional Investment Advisors LLC boosted its holdings in shares of National HealthCare by 38.6% in the fourth quarter. Morgan Stanley Institutional Investment Advisors LLC now owns 1,038,787 shares of the company’s stock worth $142,407,000 after buying an additional 289,566 shares during the last quarter. First Trust Advisors LP increased its holdings in National HealthCare by 45.4% during the first quarter. First Trust Advisors LP now owns 530,302 shares of the company’s stock valued at $84,689,000 after buying an additional 165,615 shares during the last quarter. Geode Capital Management LLC raised its position in National HealthCare by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 318,440 shares of the company’s stock worth $43,662,000 after acquiring an additional 2,361 shares during the period. Goldman Sachs Group Inc. raised its position in National HealthCare by 43.5% in the fourth quarter. Goldman Sachs Group Inc. now owns 85,781 shares of the company’s stock worth $11,760,000 after acquiring an additional 26,020 shares during the period. Finally, Arrowstreet Capital Limited Partnership boosted its stake in shares of National HealthCare by 407.2% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 75,257 shares of the company’s stock worth $12,019,000 after acquiring an additional 60,420 shares during the last quarter. Institutional investors own 56.44% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on NHC. BMO Capital Markets raised shares of National HealthCare to a “hold” rating in a research report on Monday, May 18th. Royal Bank Of Canada raised National HealthCare to a “hold” rating in a report on Monday, May 18th. Robert W. Baird upgraded National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. Finally, The Goldman Sachs Group raised National HealthCare to a “strong-buy” rating in a report on Monday, May 18th. Two research analysts have rated the stock with a Strong Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy”.

National HealthCare Trading Up 1.7%

NYSEAMERICAN NHC opened at $223.59 on Friday. National HealthCare Corporation has a 12 month low of $105.50 and a 12 month high of $232.67. The stock has a market cap of $3.50 billion, a price-to-earnings ratio of 25.15 and a beta of 0.61. The company’s 50 day moving average is $212.50 and its two-hundred day moving average is $184.22.

National HealthCare (NYSEAMERICAN:NHC) last posted its quarterly earnings results on Thursday, August 6th. The company reported $1.74 earnings per share for the quarter. The business had revenue of $408.03 million during the quarter. National HealthCare had a net margin of 9.00% and a return on equity of 10.03%.

National HealthCare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a $0.67 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $2.68 annualized dividend and a yield of 1.2%. National HealthCare’s dividend payout ratio is currently 61.89%.

Insiders Place Their Bets

In other National HealthCare news, Director Lisa Piercey purchased 949 shares of the business’s stock in a transaction on Monday, June 1st. The stock was acquired at an average price of $184.26 per share, for a total transaction of $174,862.74. Following the purchase, the director owned 949 shares of the company’s stock, valued at approximately $174,862.74. This represents a ? increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 13.92% of the company’s stock.

About National HealthCare

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.